Integrating Effect-Directed Analysis and Chemically Indicative Mass Spectral Fragmentation to Screen for Toxic Organophosphorus Compounds.
Dan LoewenthalShai DaganEyal DrugPublished in: Analytical chemistry (2023)
Analytical chemists are often challenged to screen for bioactive compounds in complex matrices, sometimes without a priori knowledge of the exact compound of interest. Therefore, "flagging" techniques, highlighting common characteristics of bioactive compounds, are highly sought after. In this work, we demonstrate a double flagging method, where unknown organophosphorus acetylcholinesterase inhibitors are "flagged" out of a complex matrix by the presence of organophosphorus-indicative ions as well as their acetylcholinesterase inhibition. This is accomplished by flagging the LC chromatographic retention time of phosphorus-indicative ions using accurate mass high-energy in-source CID products, and the retention time of acetylcholinesterase inhibiting compounds using a parallel microfractionation-based bioassay. We successfully apply this method to screen VX, VM, and RVX nerve agents as well as methomyl, a carbamate pesticide, out of soil and whole blood samples at low μM to sub-μM concentrations. This methodology can be easily extended to diverse chemical families and biological activities of interest.
Keyphrases
- aqueous solution
- high throughput
- simultaneous determination
- healthcare
- risk assessment
- optical coherence tomography
- signaling pathway
- liquid chromatography
- mass spectrometry
- high resolution
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- peripheral nerve
- quantum dots
- contrast enhanced
- data analysis